ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Clinical trials for ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN explained in plain language.

Never miss a new study

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN trials appear

Sign up with your email to follow new studies for ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Immune-Boosting drug tested to tame seasonal allergies

Symptom relief Completed

This study tested whether a drug called ILT-101 (low-dose IL-2) could reduce allergy symptoms in people allergic to birch pollen. Twenty-four adults received either the drug or a placebo for 36 days to see if it lessened their nasal congestion and other symptoms when exposed to b…

Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief

Last updated Apr 03, 2026 14:41 UTC

ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN trials appear

Immune-Boosting drug tested to tame seasonal allergies